CN106110232A - A kind of decoction medicine treating chronic type B viral hepatitis and preparation method thereof - Google Patents
A kind of decoction medicine treating chronic type B viral hepatitis and preparation method thereof Download PDFInfo
- Publication number
- CN106110232A CN106110232A CN201610808351.4A CN201610808351A CN106110232A CN 106110232 A CN106110232 A CN 106110232A CN 201610808351 A CN201610808351 A CN 201610808351A CN 106110232 A CN106110232 A CN 106110232A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- fructus
- medicine
- viral hepatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
nullThe invention belongs to technical field of Chinese medicine,Purpose is a kind of decoction medicine treating chronic type B viral hepatitis according to the traditional Chinese medical science, chronic type B viral hepatitis being recognized mechanism and providing,Each component of described medicine and mass parts ratio thereof are as follows: the Radix Astragali 15~32g、Radix Salviae Miltiorrhizae 5~20g、Folium Malloti Apeltae 25~45g、Fructus Ligustri Lucidi 8~16g、Fructus Lycii 10~22g、Rhizoma Smilacis Glabrae 15~55g、Radix Bupleuri 3~12g、Poria 15~26g、Fructus Schisandrae Chinensis 3~6g、Radix Codonopsis 15~26g、Rhizoma Pinelliae (processed) 3~9g、Rhizoma Dioscoreae 15~32g、Radix Isatidis 30~48g、The Rhizoma Atractylodis Macrocephalae 8~16g、Radix Curcumae 8~16g、The Radix Paeoniae Alba (wine stir-fry) 10~22g、Herba Hedyotidis Diffusae 15~30g、Radix Angelicae Sinensis 8~16g、Pericarpium Citri Reticulatae 6~10g、Flos Lonicerae 15~26g、Rhizoma Polygonati 15~25g、Rhizoma Polygoni Cuspidati 15~30g、Fructus Crataegi (parched to brown) 3~10g;The medicine that the present invention provides is a good Chinese prescription.
Description
Technical field
The present invention relates to technical field of Chinese medicine, be specifically related to a kind of decoction medicine treating chronic type B viral hepatitis
Thing, particularly for the field of decoction medicine and preparation method thereof of chronic type B viral hepatitis patient.
Background technology
Previously there are hepatitis B or HBVsAg to carry history or the acute hepatitis course of disease exceedes half a year, and still have hepatitis disease at present
Shape, sign and abnormal liver function person can be diagnosed as chronic viral hepatitis B.Though date of the onset is failed to understand or without history of virus hepatitis, but iconography,
Peritoneoscope or Liver biopsy pathological examination meet chronic hepatitis and change or comprehensively analyze according to symptom, sign, chemical examination and also may be used
Make corresponding diagnosis.According to world's disease for digest meeting in 1994 by the development classification of chronic hepatitis B with by stages and accordingly by the state of an illness
Degree indexing.The slight state of an illness is relatively light, and clinical symptoms is inconspicuous, just finds that ALT raises or HBsAg is positive when simply having a medical check-up.Liver
Biopsy performance G1-2, course inflammatory activity degree S0-2, fibrosis.Though this type of conditions of patients delay several years, but total trend can be by
Gradually taking a turn for the better so that recovery from illness, only minority transfers moderate chronic hepatitis to.Moderate symptoms, sign, lab testing occupy slight and weight
Between degree, liver biopsy G3, S2-3.Severe has obvious or lasting hepatitis symptom, such as weak, poor appetite, nauseating, abdominal distention, upper right abdomen
Dull pain, loose stool etc., can get rid of other reasons and nothing with chronic hepatopathy face, liver palm, typical spider angioma or hepatosplenomegaly
Portal hypertension person.Lab testing Serum ALT raises repeatedly or persistently, and albumin lowers or A/G abnormal proportion, gamma globulin
Significantly raised.In addition to aforementioned condition, all albumin≤32g/L, bilirubin are more than 5 times of upper limits of normal, Prothrombin activity
40%-60%, acetylcholine esterase≤2500U/L, in these four detections, 1 reaches above-mentioned standard person and can be diagnosed as severe chronic hepatitis B.
Liver biopsy G4, S3-4.
The treatment of chronic hepatitis B, mainly based on antiviral therapy, is aided with simultaneously and protects the liver, and immune modulating treatment reaches
Suppression virus replication, promotes virus sweep, alleviates inflammation and downright bad promotion hepatocyte is repaired, stop or delay of progression is liver
Hardening, reduces the Probability of HBV associated hepatocellular carcinoma, improves the quality of life of patient, extends the life cycle of patient, alleviates, subtracts
Light clinical symptoms.Antiviral drugs currently mainly is interferon and nucleoside analog, and interferon (IFN) has antiviral, resists
Cell proliferation and immunoregulation effect.Interferon anti-reflecting virus effect is to show can be with the IFN receptor phase in surface of hepatocytes
In conjunction with, by intracellular Information Conduction, the expression of induction antiviral protein, interference DNA synthesizes and the synthesis of virus protein, from
And stop virus replication.Owing to the virus-cell system of different Infection Status is different to the sensitivity of α-IFN, immunne response is lived
Jump, hepatocyte inflammation is easily generated effect time obvious.IFN treatment hepatitis B condition requires that HBV is in duplication state, and ALT exceedes normally
2-10 times of the upper limit, ALT is normal but hepatic tissue has obvious inflammation, G2-G4, or has hepatic fibrosis to be formed, and the untoward reaction of IFN is
Commonly flu syndrome, 2-4 hour the most after injection, performance heating, shiver with cold, myalgia etc., typically use acetyl aminophenol
Etc. anti symptom treatment, severe reaction such as psychological problem, arrhythmia, bone marrow depression, nephrotic syndrome etc. should be seen in drug withdrawal immediately
Examine.This type of drug main of nucleoside analog Entecavir to be had, lamivudine, famciclovir, adefovirdipivoxil, Lobucavir, left-handed-
Fluorine methylurea pyrimidine, cyclohexanedione hydroxyphenylpyruvate dioxygenase carbon deoxyguanosine etc..Lamivudine is replicated with stronger inhibitory action to viruses such as HBV, HIV,
Therefore application is universal in clinic.Lamivudine is inhibited to HBV polymerase and reverse transcriptase, thus suppresses virus replication
Process of reverse-transcription in circulation, the synthesis of blocking virus DNA.But can not suppress and remove the superhelix knot of hepatocyte inner virus
Structure cccDNA, therefore virus may replicate once again after drug withdrawal, therefore needs long-term taking to obtain lasting effects.Lamivudine stops disease
The expressional function of toxalbumin is weak, so HBeAg negative conversion rate is low.Famciclovir is a kind of efficient, low toxicity antiviral drugs.It was both made
For archaeal dna polymerase and virus process of reverse-transcription, the duplication of suppression HBVDNA, act on again the formation of cccDNA simultaneously.General former times
Luo Wei treatment also can cause the variation of HBV, has crossing drug resistant with lamivudine.After short term therapy drug withdrawal, relapse rate is the highest.
So, with regard to how finding a kind of medicine that can effectively treat above-mentioned chronic type B viral hepatitis, it is that we are current
Problem in urgent need to solve.
Summary of the invention
Along with the development of China's Chinese medicine, on treatment chronic type B viral hepatitis, people gradually realize
The advantage having arrived the above-mentioned chronic type B viral hepatitis of Chinese traditional treatment, and that toxic and side effects is little over the course for the treatment of, expense is low etc. is excellent
Gesture, for the present situation of the above-mentioned hepatitis B of existing western medical treatment, it is an object of the invention to be to provide one to treat slow virus
The decoction medicine of property hepatitis B, to solve the most restorative problem of chronic type B viral hepatitis patient.This medicine is
With common Chinese medicine as raw material, there is instant effect, the feature such as evident in efficacy, and can effectively treat the B-mode liver of above-mentioned chronic viral
Scorching.
For reaching the purpose of foregoing invention, the technical solution adopted in the present invention is: provide one to treat chronic viral
Decoction medicine of hepatitis B and preparation method thereof, it is characterised in that each component of described medicine and mass parts ratio thereof are as follows
Shown in:
The Radix Astragali 15~32g, Radix Salviae Miltiorrhizae 5~20g, Folium Malloti Apeltae 25~45g, Fructus Ligustri Lucidi 8~16g, Fructus Lycii 10~22g, Rhizoma Smilacis Glabrae 15
~55g, Radix Bupleuri 3~12g, Poria 15~26g, Fructus Schisandrae Chinensis 3~6g, Radix Codonopsis 15~26g, Rhizoma Pinelliae (processed) 3~9g, Rhizoma Dioscoreae 15~
32g, Radix Isatidis 30~48g, the Rhizoma Atractylodis Macrocephalae 8~16g, Radix Curcumae 8~16g, the Radix Paeoniae Alba (wine stir-fry) 10~22g, Herba Hedyotidis Diffusae 15~30g,
Radix Angelicae Sinensis 8~16g, Pericarpium Citri Reticulatae 6~10g, Flos Lonicerae 15~26g, Rhizoma Polygonati 15~25g, Rhizoma Polygoni Cuspidati 15~30g, Fructus Crataegi (parched to brown) 3~10g.
A kind of decoction medicine treating chronic type B viral hepatitis and preparation method thereof, it is characterised in that described medicine
Each component and mass parts ratio as follows:
The Radix Astragali 18~28g, Radix Salviae Miltiorrhizae 12~17g, Folium Malloti Apeltae 30~40g, Fructus Ligustri Lucidi 10~14g, Fructus Lycii 12~20g, Rhizoma Smilacis Glabrae
20~48g, Radix Bupleuri 7~11g, Poria 18~23g, Fructus Schisandrae Chinensis 4~5.5g, Radix Codonopsis 18~23g, Rhizoma Pinelliae (processed) 6~8g, Rhizoma Dioscoreae 18
~28g, Radix Isatidis 35~42g, the Rhizoma Atractylodis Macrocephalae 10~14g, Radix Curcumae 10~14g, the Radix Paeoniae Alba (wine stir-fry) 12~20g, Herba Hedyotidis Diffusae 18~
26g, Radix Angelicae Sinensis 10~14g, Pericarpium Citri Reticulatae 7~9g, Flos Lonicerae 18~23g, Rhizoma Polygonati 18~22g, Rhizoma Polygoni Cuspidati 18~26g, Fructus Crataegi (parched to brown) 7~9g.
A kind of decoction medicine treating chronic type B viral hepatitis and preparation method thereof, it is characterised in that described " optimal
Scheme " each component of medicine and mass parts ratio as follows:
Radix Astragali 25g, Radix Salviae Miltiorrhizae 15g, Folium Malloti Apeltae 35g, Fructus Ligustri Lucidi 13g, Fructus Lycii 17g, Rhizoma Smilacis Glabrae 42g, Radix Bupleuri 10g, Poria 20g,
Fructus Schisandrae Chinensis 5g, Radix Codonopsis 20g, Rhizoma Pinelliae (processed) 7g, Rhizoma Dioscoreae 25g, Radix Isatidis 36g, Rhizoma Atractylodis Macrocephalae 13g, Radix Curcumae 13g, the Radix Paeoniae Alba (wine stir-fry) 17g,
Herba Hedyotidis Diffusae 23g, Radix Angelicae Sinensis 13g, Pericarpium Citri Reticulatae 8g, Flos Lonicerae 20g, Rhizoma Polygonati 20g, Rhizoma Polygoni Cuspidati 23g, Fructus Crataegi (parched to brown) 8g.
A kind of decoction medicine treating chronic type B viral hepatitis and preparation method thereof, it is characterised in that described method
Comprise the steps to be prepared from:
A, above-mentioned raw materials Chinese medicine is picked decontamination and dust after, be respectively crushed into coarse according to mass parts ratio and decoct a drug wrapped;
B, the raw material Chinese medicine wrapped is put in cold boiled water immersion half an hour, the most again by soaked medicine with soak medicine
Marmite put in the lump by the clear liquor of thing, and the cold boiled water injecting medicine 35mm carries out decocting 45 minutes for the first time, after leaching medicinal liquid,
The tepor boiled water re-injecting medicine 32mm carries out decocting 35 minutes for the second time, and secondary mixing is condensed into the herb liquid 1080 of 50%
Milliliter is standby.
A kind of decoction medicine treating chronic type B viral hepatitis and preparation method thereof, it is characterised in that described in take
Method is: being divided by the herb liquid prepared two days and take, the morning, noon and afternoon service once, dosage 180 milliliter/time, and taking medicine before meal serve on
3~6 months (starting the dose that successively decreases from four month), symptom gradually alleviates or fully recovers.
Each raw material Chinese medicine in prescription of the present invention all has detailed note in Chinese Pharmacopoeia, China's dictionary and China's book on Chinese herbal medicine
Carry.The present invention selects most common of which Chinese medicine to be raw material, gives full play to the pharmacological effect of each component:
The Radix Astragali, nature and flavor: sweet, tepor, there is invigorating QI to consolidate the body surface resistance, diuresis poison holding, evacuation of pus, effect of expelling pus and promoting granulation, be used for treating the deficiency of vital energy
Weak, anorexia and loose stool, sinking of QI of middle-JIAO, chronic diarrhea proctoptosis, metrorrhagia of having blood in stool, exterior deficiency spontaneous perspiration, deficiency of vital energy edema, carbuncle difficulty burst, burst for a long time do not hold back,
The diseases such as blood deficiency dull yellowish colored skin, interior-heat are quenched one's thirst, chronic nephritis proteinuria, diabetes;
Radix Salviae Miltiorrhizae, nature and flavor: bitter, be slightly cold, there is promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, effect of nourishing blood to tranquillize the mind,
For treating menoxenia, amenorrhea dysmenorrhea, lump in the abdomen, chest and abdomen twinge, pyretic arthralgia pain, skin infection swell and ache, dysphoria and insomnia, liver splenomegaly
Greatly, the disease such as angina pectoris;
Folium Malloti Apeltae, nature and flavor: micro-hardship, puckery, flat, root: have easing the affected liver invigorate blood circulation, invigorating the spleen for eliminating dampness, the solid de-effect of convergence, be used for treating slow
Property hepatitis, hepatosplenomegaly, uterine prolapse, proctoptosis, leucorrhea, edema during pregnancy, leaf: anti-inflammation hemostasia, external is controlled otitis media, furuncle and phyma, is fallen
Make damage, traumatic hemorrhage;
Fructus Ligustri Lucidi, nature and flavor: sweet, bitter, cool in nature, there is effect of liver and kidney tonifying, clearind deficient heat, improving eyesight, be used for treating Light-headedness, waist
The diseases such as knees soreness, seminal emission, tinnitus, early whitening of beard and hair, osteopyrexia and fever, poor vision;
Fructus Lycii, nature and flavor: sweet in the mouth, property are flat, have effect of nourishing the liver, nourishing kidney, lung moistening, be used for treating caused by liver and kidney deficiency, have a dizzy spell,
Visual one clear, the expensive essence of soreness of the waist and knees, sexual impotence, cough due to consumptive disease, the diseases such as taking fluids profusely of quenching one's thirst;
Rhizoma Smilacis Glabrae, nature and flavor: sweet, light, flat, there is dehumidifying, removing toxic substances, effect of easing joint movement, be used for treating damp and hot stranguria with turbid discharge, leukorrhagia,
Carbuncle, scrofula, scabies, syphilis and the limbs contracture caused by mercurialism, bones and muscles pain;
Radix Bupleuri, nature and flavor: bitter in the mouth, pungent, cold nature, having induces sweat brings down a fever, effect of dispersing the stagnated live-QI to relieve the stagnation of QI, liter act yang-energy, outside being used for treating
Sense heating, alternate attack of chill and fever, malaria, hypochondriac pain due to stagnation of liverQI mammary swelling, have a headache dizziness, menoxenia, the proctoptosis of collapse of QI, uterine prolapse,
Gastroptosis;
Poria, nature and flavor: sweet, light, flat, there is effect of eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, mind tranquilizing and the heart calming, be used for treating dysuria,
Edema distension, phlegm retention cough with dyspnea, vomiting, insufficiency of the spleen lack of appetite, have loose bowels, palpitation and restlessness, insomnia forgetfulness, the disease such as seminal emission nebulousurine;
Fructus Schisandrae Chinensis, nature and flavor: sour, sweet, warm, there is convergence astringent or styptic treatment for spontaneous sweating, supplementing QI for promoting the production of body fluid, effect of kidney calming, be used for treating chronic diarrhea not
Only, chronic cough dyspnea due to deficiency, cardiopalmus, insomnia, dreaminess, spontaneous perspiration, night sweat, Tianjin wound is thirsty, quench one's thirst, pass out semen, spermatorrhea;
Radix Codonopsis, nature and flavor: sweet in the mouth, property are flat, have effect of strengthening the spleen and tonifying the lung, supplementing QI for promoting the production of body fluid, are used for treating weakness of the spleen and stomach, lack of appetite just
The diseases such as half congealed, limbs fatigue, the deficiency of the lung are breathed with cough, spontaneous perspiration of breathing hard, feeble QI two lose;
Rhizoma Pinelliae (processed), nature and flavor: pungent, warm, poisonous, there is effect of drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass, be used for treating wet
Expectorant cold drink, vomiting, regurgitation, cough with asthma abundant expectoration, chest and diaphragm distension, syncope due to accumulation of phlegm headache, dizzy sleeplessness, the disease such as outer subduing inflammation;
Rhizoma Dioscoreae, nature and flavor: sweet, flat, have spleen reinforcing, support lung, reinforce the kidney, effect of benefit essence, be used for treating diarrhea due to hypofunction of the spleen, lack of appetite edema,
Cough and asthma due to lung deficiency, quench one's thirst, pass out semen, leukorrhagia, frequent micturition of suffering from a deficiency of the kidney, the disease such as carbuncle, scrofula is controlled in external;
Radix Isatidis, nature and flavor: bitter, cold, nontoxic, there is effect of heat clearing away, removing toxic substances, removing heat from blood, sore-throat relieving, be used for treating maculae caused by violent heat pathogen, height
Heat headache, major part pestilence, crimson tongue are purple dark, scarlet fever, erysipelas, mumps, sore throat, skin ulcer swell, carbuncle, chickenpox, measles, hepatitis, stream
Row sexuality emits, epidemic encephalitis, encephalitis b, pneumonia, coma tell nosebleed, pharyngeal swelling, acute catarrhal conjunctivitis, skin ulcer rash, can prevent and treat epidemic encephalitis type B, acute and chronic liver
Inflammation, mumps, osteomyelitis;
The Rhizoma Atractylodis Macrocephalae, nature and flavor: bitter in the mouth, sweet, warm in nature, there is invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis, antiabortive effect, be used for treating temper
The few abdominal distention of weakness, spiritlessness and weakness, lack of appetite, big loose stool are thin, fluid-retention stagnating in the interior, dysuria, edema, dizziness due to fluid-retention, temperature numbness are ached, gas
The empty disease such as spontaneous perspiration, frequent fetal movement;
Radix Curcumae, nature and flavor: acrid in the mouth, hardship, cold in nature, there is promoting blood circulation and stopping pain, promoting QI circulation for relieving depression, the removing heat from blood that clears away heart-fire, effect of depressed liver-energy dispersing and function of gallbladder promoting, use
In the treatment chest and abdomen side of body all pains of rib, dysmenorrhes, amenorrhea, lump in the abdomen caking, calentura coma, demented, infantile convulsion, spit blood, standby, the stranguria with blood of being defeated in battle,
The disease such as sand Stranguria, jaundice;
The Radix Paeoniae Alba (wine stir-fry), nature and flavor: bitter, acid, be slightly cold, have nourish blood and seek, relieving spasm to stop pain, effect of yin fluid astringing suppressing the hyperactive liver, be used for treating
Menoxenia, abdominal pain during menstruation, metrorrhagia, spontaneous perspiration, night sweat, side of body rib epigastric pain, limb pain twin, headache, dizziness, blood deficiency and yellow complexion etc.
Disease;
Herba Hedyotidis Diffusae, nature and flavor: bitter but sweet flavor, cold in nature, there is effect of heat clearing away, dampness removing, removing toxic substances, be used for treating dyspnea and cough due to lung-heat, flat
Fructus Persicae body inflammation, pharyngolaryngitis, appendicitis, dysentery, jaundice, pelvic inflammatory disease, adnexitis, carbuncle furuncle, venom;
Radix Angelicae Sinensis, nature and flavor: warm in nature, sweet in the mouth is pungent, there is benefiting blood and regulating blood circulation, menstruction regulating and pain relieving, moisturize effect of laxation, be used for treating blood deficiency,
Shallow complexion, dizziness cardiopalmus, blood deficiency or have concurrently the stagnant menoxenia of the stasis of blood, amenorrhea, dysmenorrhea, deficient cold type stomachache, the coronary heart disease heart strand
Bitterly, the disease such as rheumatic arthralgia, traumatic injury;
Pericarpium Citri Reticulatae, nature and flavor: acrid in the mouth, hardship, warm in nature, have regulate the flow of vital energy and in, drying dampness to eliminate phlegm, effect of diuretic relieving constipation, be used for treating taste
Discord, abdominal distention, anorexia, vomiting hiccup, accumulation of phlegm-damp in the lung, cough with copious phlegm, chest and diaphragm full the most vexed, the vertigo, edema, urine
Unfavorable, constipation, acute mastitis scabies, middle fish Eriocheir sinensis poison, alcoholism etc.;
Flos Lonicerae, nature and flavor: sweet, cold, there is effect of heat clearing away, removing toxic substances, be used for treating epidemic febrile disease heating, toxic-heat and blood stasis, carbuncle and ulcer, swelling
The diseases such as poison, scrofula, anal fistula;
Rhizoma Polygonati, nature and flavor: sweet, flat, there is invigorating the spleen and replenishing QI, moisten cardiopulmonary, effect of bone and muscle strengthening, be used for treating deficient cold and heat, pulmonary tuberculosis is coughed
Blood, after being ill body void lack of appetite, muscles and bones weakness, rheumatalgia, wind favus disease;
Rhizoma Polygoni Cuspidati, nature and flavor: bitter, sour, cold nature, there is effect of promoting blood circulation to remove blood stasis, dispelling wind and removing obstruction in the collateral, clearing away heat-damp and promoting diuresis, removing toxic substances, be used for treating
The accumulation of women's amenorrhea, dysmenorrhea, lochiostasis, abdominal mass, injury from falling down, rheumatic arthralgia, jaundice due to damp-heat, stranguria with turbid discharge leukorrhagia, skin infection swell
The diseases such as poison, venom, burn due to hot liquid or fire;
Fructus Crataegi (parched to brown), nature and flavor: sweet, the tepor of acid, nontoxic, have help digestion long-pending, change effect of the stagnant stasis of blood, gastral cavity abdomen stagnant for Therapeutic diet
The diseases such as distending pain, dysentery, dysmenorrhea due to blood stasis, amenorrhea, puerperal abdonimal pain, lochiorrhea.
Medicine of the present invention is differential diagnosis of diseases based on Chinese traditional treatment chronic type B viral hepatitis and the dialectical principle combined, from
Pharmacological action and mechanism of action are thought: with regard to chronic type B viral hepatitis, each raw material Chinese medicine in medicine provided by the present invention
Drug effect is played altogether, and above-mentioned disease is had good therapeutic effect.
Detailed description of the invention
A kind of Chinese medicine formula that the present invention is aiming at the treatment of above-mentioned chronic type B viral hepatitis and proposes, using should
Medicine effect prepared by formula is good, instant effect, is the Chinese prescription of a treating both the principal and secondary aspects of a disease, is particularly suitable for Clinical practice.Tie below
The detailed description of the invention closing the present invention is described in further detail:
Embodiment 1:
A kind of decoction medicine treating chronic type B viral hepatitis, it is characterised in that each component of described medicine and matter thereof
Amount part ratio is as follows:
Radix Astragali 25g, Radix Salviae Miltiorrhizae 15g, Folium Malloti Apeltae 35g, Fructus Ligustri Lucidi 13g, Fructus Lycii 17g, Rhizoma Smilacis Glabrae 42g, Radix Bupleuri 10g, Poria 20g,
Fructus Schisandrae Chinensis 5g, Radix Codonopsis 20g, Rhizoma Pinelliae (processed) 7g, Rhizoma Dioscoreae 25g, Radix Isatidis 36g, Rhizoma Atractylodis Macrocephalae 13g, Radix Curcumae 13g, the Radix Paeoniae Alba (wine stir-fry) 17g,
Herba Hedyotidis Diffusae 23g, Radix Angelicae Sinensis 13g, Pericarpium Citri Reticulatae 8g, Flos Lonicerae 20g, Rhizoma Polygonati 20g, Rhizoma Polygoni Cuspidati 23g, Fructus Crataegi (parched to brown) 8g.
Embodiment 2:
A kind of decoction medicine treating chronic type B viral hepatitis, it is characterised in that each component of described medicine and matter thereof
Amount part ratio is as follows:
Radix Astragali 28g, Radix Salviae Miltiorrhizae 17g, Folium Malloti Apeltae 40g, Fructus Ligustri Lucidi 14g, Fructus Lycii 20g, Rhizoma Smilacis Glabrae 48g, Radix Bupleuri 11g, Poria 23g,
Fructus Schisandrae Chinensis 5.5g, Radix Codonopsis 23g, Rhizoma Pinelliae (processed) 8g, Rhizoma Dioscoreae 28g, Radix Isatidis 42g, Rhizoma Atractylodis Macrocephalae 14g, Radix Curcumae 14g, the Radix Paeoniae Alba (wine stir-fry)
20g, Herba Hedyotidis Diffusae 26g, Radix Angelicae Sinensis 14g, Pericarpium Citri Reticulatae 9g, Flos Lonicerae 23g, Rhizoma Polygonati 22g, Rhizoma Polygoni Cuspidati 26g, Fructus Crataegi (parched to brown) 9g.
Embodiment 3:
A kind of decoction medicine treating chronic type B viral hepatitis, it is characterised in that each component of described medicine and matter thereof
Amount part ratio is as follows:
Radix Astragali 32g, Radix Salviae Miltiorrhizae 20g, Folium Malloti Apeltae 45g, Fructus Ligustri Lucidi 16g, Fructus Lycii 22g, Rhizoma Smilacis Glabrae 55g, Radix Bupleuri 12g, Poria 26g,
Fructus Schisandrae Chinensis 6g, Radix Codonopsis 26g, Rhizoma Pinelliae (processed) 9g, Rhizoma Dioscoreae 32g, Radix Isatidis 48g, Rhizoma Atractylodis Macrocephalae 16g, Radix Curcumae 16g, the Radix Paeoniae Alba (wine stir-fry) 22g,
Herba Hedyotidis Diffusae 30g, Radix Angelicae Sinensis 16g, Pericarpium Citri Reticulatae 10g, Flos Lonicerae 26g, Rhizoma Polygonati 25g, Rhizoma Polygoni Cuspidati 30g, Fructus Crataegi (parched to brown) 10g.
Model case:
Through clinical conditions chronic type B viral hepatitis patient totally 210 example, the age is 130 examples of more than 29 years old, only 80
Example is less than 29 years old.180 examples of recovery from illness in 210 example patients, 30 effective examples, total effective rate reaches 100%.Through treatment after, symptom by
Decrescence light or recovery from illness.
Claims (3)
1. the decoction medicine treating chronic type B viral hepatitis, it is characterised in that each component of described medicine and
Mass parts ratio is as follows:
The Radix Astragali 15~32g, Radix Salviae Miltiorrhizae 5~20g, Folium Malloti Apeltae 25~45g, Fructus Ligustri Lucidi 8~16g, Fructus Lycii 10~22g, Rhizoma Smilacis Glabrae 15
~55g, Radix Bupleuri 3~12g, Poria 15~26g, Fructus Schisandrae Chinensis 3~6g, Radix Codonopsis 15~26g, Rhizoma Pinelliae (processed) 3~9g, Rhizoma Dioscoreae 15~
32g, Radix Isatidis 30~48g, the Rhizoma Atractylodis Macrocephalae 8~16g, Radix Curcumae 8~16g, the Radix Paeoniae Alba (wine stir-fry) 10~22g, Herba Hedyotidis Diffusae 15~30g,
Radix Angelicae Sinensis 8~16g, Pericarpium Citri Reticulatae 6~10g, Flos Lonicerae 15~26g, Rhizoma Polygonati 15~25g, Rhizoma Polygoni Cuspidati 15~30g, Fructus Crataegi (parched to brown) 3~10g.
The decoction medicine for the treatment of chronic type B viral hepatitis the most according to claim 1, it is characterised in that described medicine
Each component and mass parts ratio as follows:
The Radix Astragali 18~28g, Radix Salviae Miltiorrhizae 12~17g, Folium Malloti Apeltae 30~40g, Fructus Ligustri Lucidi 10~14g, Fructus Lycii 12~20g, Rhizoma Smilacis Glabrae
20~48g, Radix Bupleuri 7~11g, Poria 18~23g, Fructus Schisandrae Chinensis 4~5.5g, Radix Codonopsis 18~23g, Rhizoma Pinelliae (processed) 6~8g, Rhizoma Dioscoreae 18
~28g, Radix Isatidis 35~42g, the Rhizoma Atractylodis Macrocephalae 10~14g, Radix Curcumae 10~14g, the Radix Paeoniae Alba (wine stir-fry) 12~20g, Herba Hedyotidis Diffusae 18~
26g, Radix Angelicae Sinensis 10~14g, Pericarpium Citri Reticulatae 7~9g, Flos Lonicerae 18~23g, Rhizoma Polygonati 18~22g, Rhizoma Polygoni Cuspidati 18~26g, Fructus Crataegi (parched to brown) 7~9g.
3. according to the decoction medicine of the treatment chronic type B viral hepatitis described in claim 1 to 2, it is characterised in that described
Each component of medicine and mass parts ratio thereof are as follows:
Radix Astragali 25g, Radix Salviae Miltiorrhizae 15g, Folium Malloti Apeltae 35g, Fructus Ligustri Lucidi 13g, Fructus Lycii 17g, Rhizoma Smilacis Glabrae 42g, Radix Bupleuri 10g, Poria 20g,
Fructus Schisandrae Chinensis 5g, Radix Codonopsis 20g, Rhizoma Pinelliae (processed) 7g, Rhizoma Dioscoreae 25g, Radix Isatidis 36g, Rhizoma Atractylodis Macrocephalae 13g, Radix Curcumae 13g, the Radix Paeoniae Alba (wine stir-fry) 17g,
Herba Hedyotidis Diffusae 23g, Radix Angelicae Sinensis 13g, Pericarpium Citri Reticulatae 8g, Flos Lonicerae 20g, Rhizoma Polygonati 20g, Rhizoma Polygoni Cuspidati 23g, Fructus Crataegi (parched to brown) 8g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610808351.4A CN106110232A (en) | 2016-09-08 | 2016-09-08 | A kind of decoction medicine treating chronic type B viral hepatitis and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610808351.4A CN106110232A (en) | 2016-09-08 | 2016-09-08 | A kind of decoction medicine treating chronic type B viral hepatitis and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106110232A true CN106110232A (en) | 2016-11-16 |
Family
ID=57271316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610808351.4A Withdrawn CN106110232A (en) | 2016-09-08 | 2016-09-08 | A kind of decoction medicine treating chronic type B viral hepatitis and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106110232A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107496838A (en) * | 2017-09-15 | 2017-12-22 | 南通荣成医药化工有限公司 | A kind of pill for controlling liver removing toxic substances |
-
2016
- 2016-09-08 CN CN201610808351.4A patent/CN106110232A/en not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107496838A (en) * | 2017-09-15 | 2017-12-22 | 南通荣成医药化工有限公司 | A kind of pill for controlling liver removing toxic substances |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102166317B (en) | Traditional Chinese medicine combination for curing metrorrhagia and metrostaxis | |
CN103550517A (en) | Medicine for treating liver cancer | |
CN104707108A (en) | Traditional Chinese medicine composition for treating chronic virulent hepatitis b and preparation method thereof | |
CN103156934A (en) | Traditional Chinese medicine for treating apoplexy sequela | |
CN1250275C (en) | Traditional Chinese medicine for treating cancer and preparation method thereof | |
CN105943705A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
CN106110232A (en) | A kind of decoction medicine treating chronic type B viral hepatitis and preparation method thereof | |
CN104771578A (en) | Traditional Chinese medicine for treating allergic rhinitis | |
CN102671056B (en) | Chinese medicinal composition for treating hepatitis and preparation method thereof | |
CN101461857B (en) | Medicament for treating severe hepatitis | |
CN106177392A (en) | A kind of decoction medicine treating exogenous high fever and preparation method thereof | |
CN106267022A (en) | A kind of medicine treating the viral myocarditis that deficiency of both QI and YIN causes and preparation method | |
CN103212033B (en) | Drug composition for treating viral hepatitis | |
CN102552789A (en) | Chinese medicine for treating damp-warm flu and preparation method and application thereof | |
CN105687897A (en) | Pure traditional Chinese medicine preparation for treating diabetes and preparation method of pure traditional Chinese medicine preparation for treating diabetes | |
CN106177642A (en) | A kind of endo-medicine treating rheumatoid arthritis and preparation method thereof | |
CN101015671B (en) | Chinese patent drug for treating cirrhosis | |
CN106139111A (en) | A kind of can effective Chinese medicine composition treating depression and preparation method thereof | |
CN106215165A (en) | A kind of Chinese medicine composition for treating wind and cold type of blood-stasis obstructing in the interior scapulohumeral periarthritis | |
CN106074918A (en) | A kind of soothing the liver fat Chinese medicine composition that disappears treating non-alcohol fatty liver | |
CN105709176A (en) | Traditional Chinese medicine composition for treating heart blood stasis type palpitation and preparation method thereof | |
CN105288143A (en) | Traditional Chinese medicine composition for treating asthma | |
CN103285130A (en) | Chinese medicine composition for liver cancer treatment and preparing method thereof | |
CN106215129A (en) | A kind of Chinese medicine composition that can effectively treat chronic hepatitis Bhepatic fibrosis | |
CN103356970A (en) | Traditional Chinese medicine composition for treating mammary gland hyperplasia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20161116 |
|
WW01 | Invention patent application withdrawn after publication |